Kura Oncology Inc
(NAS:KURA)
$
8.86
-0.08 (-0.89%)
Market Cap: 688.99 Mil
Enterprise Value: 250.32 Mil
PE Ratio: 0
PB Ratio: 1.63
GF Score: 29/100 Kura Oncology Inc at Credit Suisse Healthcare Conference Transcript
Nov 09, 2022 / 06:25PM GMT
Release Date Price:
$13.5
(+1.66%)
Tiago Felipe Fauth;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
All right. Welcome, everyone, to the 31st Annual Healthcare Conference for Credit Suisse. We're joined today by Kura Oncology. We have Troy here, President and CEO of the company for a fireside chat. We're going to leave about 5 minutes towards the end of the presentation. If there are any questions from the audience. Otherwise, I just keep firing away until the time is up.
Questions & Answers
Tiago Felipe Fauth;dit Suisse AG;Troy Edward Wilson
CrÃ;Research Division - Research Analyst;Kura Oncology, Inc. - Chairman, CEO, President & Principal Financial Officer
© -
But I guess since you haven't had a public presence since the ASH abstracts were released, I know there was a lot of chat. So maybe too much focus on men in the near term, so we can probably start there. If you can just have your intro remarks, what are some of the key learnings from the abstract, and we'll take it from there.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot